Shuttle Pharmaceuticals Inc (SHPH)

Shuttle Pharmaceuticals Inc (SHPH) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $24.2M; returns 1 day +5.4%, 1 week -4.3%, 1 year -84.3%.

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company primarily focused on improving outcomes for cancer patients undergoing radiation therapy. As a pre-revenue entity, its business model is centered on the research and development of two main product categories: therapeutics and diagnostics.

Groups SHPH belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Healthcare
• Oncology
• Cancer Therapeutics
• Pharmaceuticals
• Drug Discovery
• AI in Healthcare
• Artificial Intelligence
• R&D

SHPH financial model: income statement, cash flow and balance sheet